Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Modular Medical, Inc. Market Cap
The Modular Medical, Inc. (MODD) share price is expected to increase by 153.3% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered MODD. Price targets range from $3.5 at the low end to $8 at the high end. The current analyst consensus for MODD is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
Modular Medical, Inc. has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Modular Medical, Inc. will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of MODD.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Bruce Jackson Benchmark | Speculative Buy | $5 | Reiterates | Mar 21, 2024 |
| Steven Lichtman Oppenheimer | Outperform | $3.5 | Reiterates | Sep 19, 2023 |
| Bruce Jackson Benchmark | Speculative Buy | $5 | Reiterates | Jun 30, 2023 |
| Steven Lichtman Oppenheimer | Outperform | $3.5 | Maintains | May 19, 2023 |
| Bruce Jackson Benchmark | Speculative Buy | $5 | Maintains | Jan 30, 2023 |
| Brooks O'Neil Lake Street | Buy | $11 | Initiates | Apr 8, 2022 |
Benchmark | Speculative Buy | Initiates | Mar 25, 2022 |
When did it IPO
2020
Staff Count
39
Country
United States
Sector/Industry
Healthcare/Medical Devices
CEO
Market Cap
$73.3M
In 2023, MODD generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that MODD's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 30 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Modular Medical (NASDAQ:MODD) will present at the Lytham Partners Fall 2024 Investor Conference on October 1, 2024, showcasing its FDA-cleared insulin delivery patch pump.
Why It Matters - Modular Medical's participation in the investor conference highlights its innovation in insulin delivery, potentially attracting investor interest and affecting stock performance.
Wed, 18 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Modular Medical, Inc. announced the issuance of U.S. Divisional Patent Application No. 17/968,599 for its FDA-cleared MODD1 patch pump, enhancing its insulin delivery technology for adult users.
Why It Matters - The issuance of the patent application enhances Modular Medical's competitive position and could lead to increased market share in the insulin delivery sector, potentially boosting future revenues.
Wed, 11 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Modular Medical (NASDAQ: MODD) will start a proof of concept study on its MODD1 pump for GLP-1 delivery in October 2024, with results expected in November 2024. A webinar is scheduled for September 11.
Why It Matters - The announcement of a proof-of-concept study for a new delivery system could signal potential growth and innovation for Modular Medical, impacting its stock performance and investor interest.
Mon, 09 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Modular Medical CEO Jeb Besser highlights that over 3 million Americans use daily insulin for diabetes care, with only 20% currently utilizing insulin pumps.
Why It Matters - The low adoption rate of insulin pumps indicates significant growth potential for Modular Medical, suggesting a promising market opportunity for investors in diabetes management technologies.
Wed, 04 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Modular Medical, Inc. (NASDAQ:MODD) will hold a conference call on September 5, 2024, at 8:30 a.m. ET to discuss its upcoming market expansion product in insulin delivery systems.
Why It Matters - Modular Medical's upcoming product launch and conference call could signal potential growth and market interest, impacting stock performance and investor sentiment in the insulin delivery sector.
Wed, 04 Sep 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Modular Medical (NASDAQ:MODD) received FDA clearance for its MODD1 patch pump, aimed at making diabetes technology more accessible. Commercial launch is expected in early 2025.
Why It Matters - FDA clearance for the MODD1 patch pump positions Modular Medical to capture a larger market share in diabetes management, potentially boosting revenue and stock value by addressing underserved communities.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
